Effect of CYP3A4*1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population

Journal of Clinical Pharmacy and Therapeutics

Volumn 37, Issue 2, 2012, Pages 153-156

  Dong, Z L ^a   Li, H ^b   Chen, Q X ^b   Hu, Y ^b   Wu, S J ^b   Tang, L Y ^c   Gong, W Y ^d   Xie, G H ^b   Fang, X M ^b  

^a TONGJI UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Shanghai Changning District Central Hospital   (China)

^d SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

Cytochrome p450 3a4; Fentanyl; Patient controlled analgesia; Single nucleotide polymorphisms

Indexed keywords

BUPIVACAINE; CYTOCHROME P450 3A4; FENTANYL; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A; NARCOTIC ANALGESIC AGENT;

ABDOMINAL HYSTERECTOMY; ADULT; ALLELE; ARTICLE; CHINESE; CYP3A4 GENE; DRUG EFFICACY; DRUG METABOLISM; DRUG USE; ELECTIVE SURGERY; FEMALE; GENE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; POLYMERASE CHAIN REACTION; POSTOPERATIVE ANALGESIA; RATING SCALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SATISFACTION; SINGLE NUCLEOTIDE POLYMORPHISM; VISUAL ANALOG SCALE; ASIAN; CHINA; GENETICS; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE PAIN; TIME;

ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 CYP3A; FEMALE; FENTANYL; HUMANS; HYSTERECTOMY; INFUSIONS, INTRAVENOUS; MIDDLE AGED; PAIN, POSTOPERATIVE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TIME FACTORS;

EID: 80054090832     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2011.01268.x     Document Type: Article

References (20)

1. Sia AT, Lim Y, Lim EC et al. A118G single nucleotide polymorphism of human muopioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology, 2008;109:520-526.
2. Klees TM, Sheffels P, Thummel KE, Kharasch ED Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5. Anesthesiology, 2005;102:550-556. (Pubitemid 40315144)
3. Walldén J, Lindberg G, Sandin M, Thörn SE, Wattwil M Effects of fentanyl on gastric myoelectrical activity: a possible association with polymorphisms of the muopioid receptor gene? Acta Anaesthesiologica Scandinavica, 2008;52:708-715. (Pubitemid 351549576)
4. Janicki PK, Schuler G, Francis D et al. A genetic association study of the functional A118G polymorphism of the human muopioid receptor gene inpatients with acute and chronic pain. Anesthesia and Analgesia, 2006;103:1011-1017. (Pubitemid 44576714)
5. Romberg RR, Olofsen E, Bijl H et al. Polymorphism of mu-opioid receptor gene (OPRM1:c.118A>G) does not protect against opioid-induced respiratory depression despite reduced analgesic response. Anesthesiology, 2005;102:522-530. (Pubitemid 40315140)
6. Coulbault L, Beaussier M, Verstuyft C et al. Environmental and genetic factors associated with morphine response in the postoperative period. Clinical Pharmacology and Therapeutics, 2006;79:316-324.
7. Landau R One size does not fit all: genetic variability of mu-opioid receptor and postoperative morphine consumption. Anesthesiology, 2006;105:235-237. (Pubitemid 44148165)
8. Bessler H, Shavit Y, Mayburd E, Smirnov G, Beilin B Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist. Neuroscience Letters, 2006;404:154-158. (Pubitemid 44063603)
9. Tateishi T, Krivoruk Y, Ueng YF, Wood AJ, Guengerich FP, Wood M Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation. Anesthesia and Analgesia, 1996;82:167-172. (Pubitemid 26017401)
10. Labroo RB, Paine MF, Thummel KE, Kharasch ED Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Drug Metabolism and Disposition, 1997;25:1072-1080. (Pubitemid 27396495)
11. Rodríguez-Antona C, Sayi JG, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles. Biochemical and Biophysical Research Communications, 2005;338:299-305. (Pubitemid 41540570)
12. Solus JF, Arietta BJ, Harris JR et al. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. Pharmacogenomics, 2004;5:895-931. (Pubitemid 39386756)
13. Gao Y, Zhang LR, Fu Q CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin. European Journal of Clinical Pharmacology, 2008;64:877-882.
14. Hu YF, Qiu W, Liu ZQ et al. Effects of genetic polymorphisms of CYP3A4, CYP3A5 and MDR1 on cyclosporine pharmacokinetics after renal transplantation. Clinical and Experimental Pharmacology and Physiology, 2006;33:1093-1098. (Pubitemid 44581573)
15. Liu CH, Peck K, Huang JD et al. Screening CYP3A single nucleotide polymorphisms in a Han Chinese population with a genotyping chip. Pharmacogenomics, 6:731-747.
16. Xin X, Luan X, Xiao J, Wei D, Wang J, Lu D, Yang S A modified simple RFLP-PCR method for single nucleotide polymorphism (SNP) typing. Genetics and Molecular Biology, 2006;29:562-565. (Pubitemid 44383267)
17. Samer CF, Piguet V, Dayer P, Desmeules JA Genetic polymorphism and drug interactions: their importance in the treatment of pain. Canadian Journal of Anaesthesia, 2005;52:806-821. (Pubitemid 41723655)
18. Sarton E, Romberg R, Dahan A Gender differences in morphine pharmacokinetics and dynamics. Advances in Experimental Medicine and Biology, 2003;523:71-80. (Pubitemid 36423454)
19. Tan EC, Lim Y, Teo YY, Goh R, Law HY, Sia AT Ethnic differences in pain perception and patient-controlled analgesia usage for postoperative pain. The Journal of Pain, 2008;9:849-855.
20. Chen Q, Zhou H, Wu S et al. Lack of association between TREM-1 gene polymorphisms and severe sepsis in a Chinese Han population. Human Immunology, 2008;69:220-226.